Plexxikon Report issue

Contributed to NME For profit Phase 1 Phase 2
Founded: Berkeley CA United States (2001)
Status: Acquired by Daiichi Sankyo (2011)

Organization Overview

First Clinical Trial
2006
NCT00405587
First Marketed Drug
2006
vemurafenib (zelboraf)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Plexxikon